Finance Watch: Biopharma Stocks Shocked By US FDA Volatility

Nektar, Immunic Access $400m Each From Investors

 
• By Mandy Jackson
  
Finance Watch Public Company
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Finance Watch

More from Financing